Academia.eduAcademia.edu

Outline

Consecuencias del consumo de cannabis. Revisión narrativa

Revista Española de Drogodependencias

https://doi.org/10.54108/10027

Abstract

El cannabis es la tercera droga más consumida a nivel mundial, tras el alcohol y el tabaco. En el entorno actual, con presiones para su legalización, se realizó una revisión narrativa en base a la literatura reciente, para actualizar las evidencias sobre los efectos de su consumo con fines recreativos. Se seleccionaron 19 artículos sobre consecuencias a nivel orgánico y 6 sobre acciones nocivas en la esfera psiquiátrica. A nivel orgánico, existe asociación entre el consumo de cannabis y patología cardiovascular (IAM, ACV, arritmias y con muerte súbita); a nivel respiratorio, hay asociación con bronquitis crónica y con la alteración de los volúmenes pulmonares. Se ha visto riesgo oncológico con el cáncer testicular no seminoma y más probabilidad de desarrollar cáncer primario de orofaringe. En el embarazo, hay asociación con el riesgo de bajo peso al nacer y aumento de ingresos en UCI de los neonatos. A nivel cognitivo, se han demostrado deficiencias en la memoria, atención y procesa...

References (36)

  1. Badowski, S. y Smith, G. (2020). Cannabis use during pregnancy and postpartum. Cana- dian Family Physician, 66(2), 98-103.
  2. Belladelli, F., Del Giudice, F., Kasman, A., Kold Jensen, T., Jørgensen, N., Salonia, A. y Eisenberg, M. L. (2021). The associa- tion between cannabis use and testicular function in men: A systematic review and meta-analysis. Andrology, 9(2), 503-510. https://doi.org/10.1111/andr.12953
  3. Brubacher, J. R., Chan, H., Erdelyi, S., Sta- ples, J. A., Asbridge, M. y Mann, R. E. (2022). Cannabis legalization and de- tection of tetrahydrocannabinol in in- jured drivers. New England journal of medicine, 386(2), 148-156. https://doi. org/10.1056/NEJMsa2109371
  4. Chatkin, J. M., Zani-Silva, L., Ferreira, I. y Zamel, N. (2019). Cannabis-associated asthma and allergies. Clinical Reviews in Allergy & Immunology, 56(2), 196-206.
  5. Cohen, K., Weizman, A. y Weinstein, A. (2019). Positive and negative effects of cannabis and cannabinoids on health. Clinical Pharmacology & Thera- peutics, 105(5), 1139-1147. https://doi. org/10.1002/cpt.1381
  6. Colizzi, M., Weltens, N., McGuire, P., Van Oudenhove, L. y Bhattacharyya, S. (2019). Descriptive psychopathology of the acute effects of intravenous delta- 9-tetrahydrocannabinol administration in humans. Brain Sciences, 9(4), 93. https:// doi.org/10.3390/brainsci9040093
  7. Copeland, W. E., Hill, S. N. y Shanahan, L. (2022). Adult psychiatric, substance, and functional outcomes of different defini- tions of early cannabis use. Journal of the American Academy of Child & Adolescent Psychiatry, 61(4), 533-543. https://doi. org/10.1016/j.jaac.2021.07.824
  8. De Faria, L., Mezey, L. y Winkler, A. (2021). Cannabis legalization and college mental health. Current psychiatry reports, 23(4), 1-9.
  9. Drummer, O. H., Gerostamoulos, D. y Woo- dford, N. W. (2019). Cannabis as a cau- se of death: A review. Forensic science international, 298, 298-306. https://doi. org/10.1016/j.forsciint.2019.03.007
  10. El Marroun, H., Brown, Q. L., Lund, I. O., Coleman-Cowger, V. H., Loree, A. M., Chawla, D. y Washio, Y. (2018). An epi- demiological, developmental and clinical overview of cannabis use during pregnan- cy. Preventive medicine, 116, 1-5. https:// doi.org/10.1016/j.ypmed.2018.08.036
  11. Ghosh, M. y Naderi, S. (2019). Cannabis and cardiovascular disease. Current atheros- clerosis reports, 21(6), 1-6.
  12. Gorelick, D. A. Cannabis use: Epidemiology, pharmacology, comorbidities, and ad- verse effects, 38. https://www.medilib. ir/uptodate/show/7797
  13. Gunn, J. K. L., Rosales, C. B., Center, K. E., Nu- ñez, A., Gibson, S. J., Christ, C. y Ehiri, J. E. (2016). Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analy- sis. BMJ open, 6(4), e009986. http://doi. org/10.1136/bmjopen-2015-009986
  14. Guzman, M. (2003). Cannabinoids: poten- tial anticancer agents. Nature reviews cancer, 3(10), 745-755. https://doi. org/10.1038/nrc1188
  15. Hall, W. y Degenhardt, L. (2014). The ad- verse health effects of chronic cannabis use. Drug testing and analysis, 6(1-2), 39- 45. https://doi.org/10.1002/dta.1506
  16. Hammond, C. J. (2022). Early Cannabis Expo- sure Definitions That Correspond With High Cumulative Lifetime Dose During Adolescence Are the Strongest Predic- tors of Adverse Health Outcomes. Jour- nal of the American Academy of Child and Adolescent Psychiatry, 61(5), 612-614. https://doi:10.1016/j.jaac.2022.02.008
  17. Jacobus, J., Courtney, K. E., Hodgdon, E. A. y Baca, R. (2019). Cannabis and the -de- veloping brain: What does the evidence say?. Birth defects research, 111(17), 1302- 1307. https://doi.org/10.1002/bdr2.1572
  18. Jengsuebsant, N., Benjachaya, S., Vuthiwong, J. y Tangsuwanaruk, T. (2022). Penile self-amputation due to cannabis-induced psychosis: a case report. Journal of me- dical case reports, 16(37), 1-4. https:// doi.org/10.1186/s13256-022-03267-0
  19. Joshi, M., Joshi, A. y Bartter, T. (2014). Ma- rijuana and lung diseases. Current opi- nion in pulmonary medicine, 20(2), 173-179. https://doi.org/10.1097/ MCP.0000000000000026
  20. Marconi, A., Di Forti, M., Lewis, C. M., Murray, R. M. y Vassos, E. (2016). Meta-analysis of the association between the level of can- nabis use and risk of psychosis. Schizophre- nia bulletin, 42(5), 1262-1269. https:// doi.org/10.1093/schbul/sbw003
  21. Miech, R. A., Patrick, M. E., O'Malley, P. M., Johnston, L. D. y Bachman, J. G. (2020). Trends in reported marijuana vaping among US adolescents, 2017- 2019. Jama, 323(5), 475-476. https:// doi:10.1001/jama.2019.20185
  22. Miller, N. S., Ipeku, R. y Oberbarnscheidt, T. (2020). A review of cases of mari- juana and violence. International jour- nal of environmental research and pu- blic health, 17(5), 1578. https://doi. org/10.3390/ijerph17051578
  23. National Academies of Sciences Engineering and Medicine (2017). Committee on the Revista Española de Drogodependencias 47 (4) 2022
  24. Vicente R. Ferri Reig, Carmen María Sánchez Perona, Aarati Vaswani Bolchand, Miguel Galicia Paredes y Guillermo Burillo-Putze health effects of marijuana: an evidence review and research agenda: the health effects of cannabis and cannabinoids: the current state of evidence and recom- mendations for research.
  25. Observatorio Español de las Drogas y las Adic- ciones. Estadísticas (2021). Alcohol, tabaco y drogas ilegales en España. Ministerio de Sanidad. Delegación del Gobierno para el Plan Nacional sobre Drogas; 213 p.
  26. Reece, A. S. y Hulse, G. K. (2020). Co-oc- currence across time and space of drug- and cannabinoid-exposure and adverse mental health outcomes in the National Survey of Drug Use and Health: combi- ned geotemporospatial and causal infe- rence analysis. BMC public health, 20(1), 1-15. https://doi.org/10.1186/s12889- 020-09748-5
  27. Roberts, B. A. (2019). Legalized cannabis in Colorado emergency departments: a cautionary review of negative health and safety effects. Western journal of emer- gency medicine, 20(4), 557. https://doi. org/10.5811/westjem.2019.4.39935
  28. Santos-Álvarez, I., Pérez-Lloret, P., González- Soriano, J. y Pérez-Moreno, M. (2021). Aproximación a la evaluación de la poten- cia de la resina de cannabis en Madrid: ¿Un riesgo para la salud? Adicciones. https:// doi.org/10.20882/adicciones.1630
  29. Schmid, Y., Galicia, M., Vogt, S. B., Liechti, M. E., Burillo-Putze, G., Dargan, P. I., ... & Euro-DEN Plus Research Group) (2022). Differences in clinical features associated with cannabis intoxication in presentations to European emergency departments ac- cording to patient age and sex. Clinical to- xicology, 60(8), 1-8. https://doi.org/10.1 080/15563650.2022.2060116
  30. Self, T. H., Shah, S. P., March, K. L. y Sands, C. W. (2017). Asthma associated with the use of cocaine, heroin, and marijuana: A review of the evidence. Journal of Asth- ma, 54(7), 714-722. https://doi.org/10. 1080/02770903.2016.1259420
  31. Simiyu, D. C., Jang, J. H. y Lee, O. R. (2022). Understanding Cannabis sativa L.: Current Status of Propagation, Use, Legalization, and Haploid-Inducer-Mediated Genetic Engineering. Plants, 11(9), 1236. https:// doi.org/10.3390/plants11091236
  32. Stickrath, E. (2019). Marijuana use in pregnan- cy: an updated look at marijuana use and its impact on pregnancy. Clinical obstetrics and gynecology, 62(1), 185-190 https://doi. org/10.1097/GRF.0000000000000415
  33. Subramaniam, V. N., Menezes, A. R., DeS- chutter, A. y Lavie, C. J. (2019). The cardiovascular effects of marijuana: are the potential adverse effects worth the high?. Missouri medicine, 116(2), 146.
  34. UNODC (1999). Bulletin on Narcotics -Vo- lume LI, Nos. 1 and 2, 1999 -[Internet].
  35. Volkow, N. D., Baler, R. D., Compton, W. M. y Weiss, S. R. (2014). Adverse health effects of marijuana use. New England Journal of Medicine, 370(23), 2219-2227. https:// doi.org/10.1056/NEJMra1402309
  36. Xie, M., Gupta, M. K., Archibald, S. D., Stanley Jackson, B., Young, J. E. M. y Zhang, H. (2018). Marijuana and head and neck cancer: an epidemiological re- view. Journal of Otolaryngology-Head & Neck Surgery, 47(1), 1-7. https://doi. org/10.1186/s40463-018-0319-2